Preliminary schedule
1. Afternoon Scientific session 13:30-18:00
13:30 Opening registration
14:00 Welcome and opening of the symposium
14:10 Highly pathogenic avian influenza H5 virus as a continuing pandemic threat
Prof. Ron Fouchier - Erasmus MC department of Viroscience
14:40 Organization of the National Reference Center for Respiratory pathogens: beyond detection to strengthening surveillance of bacterial and viral infections
Dr. Lize Cuypers - Laboratorium voor Klinische Microbiologie, UZ Leuven
15:00 SARI Surveillance
Ms. Yinthe Dockx - Sciensano
15:20 Wastewater-based surveillance of respiratory viruses: integration to conventional surveillance systems in Belgium
Dr. Veronik Hutse - Sciensano
15:40 Coffee break
16:10 Mycoplasma pneumoniae and other respiratory bacteria
Prof. dr. Pharm. biol. Veerle Matheeussen - UZA
16:35 Respiratory virus surveillance and real-world insight into intervention effectiveness: from genomic to using clinical virus isolates for phenotypic characterization
Prof. Peter Delputte - ReViRAnt, UAntwerpen
17:00 Pandemic preparedness: The importance of Controlled Human Infection (CHIM) studies for evaluating respiratory viral vaccines and therapeutics
dr. Bart Van Meerbergen - Vaccinopolis
17:25 Models and tools for research on respiratory viral infections
dr. Koert Stittelaar - KULeuven
2. Registration evening session and walking dinner 18:00-19:00
3. Evening policy and clinical session 19:00-20:55
19:00 Opening evening session
19:10 RSV burden of disease in children: rational for prevention and current Belgian recommendations
MD Sophie Blumental - Superior Health Council / CHIREC
19:25 Preliminary results of the Belgian National Survey on RSV pediatric burden of disease
MD Yves Lafort - Sciensano
19:40 The AS01E-adjuvanted RSVPreF3 vaccine exhibits broad efficacy against diverse RSV strains
dr. Lucile Warter - GSK
19:55 Efficacy, effectiveness and clinical development programme of RSVpreF
MD Machteld De Bock and dr. Keliane Liberman - Pfizer
20:10 Sanofi as partner in RSV prevention
MD Patrick Dhont - Sanofi
20:25 Update on MSDs advancements in RSV prevention
dr. Chloé Abels - MSD
20:40 Monitoring mild and asymptomatic respiratory infections at the community level
Prof. dr. Emmanuel André - Laboratoriumgeneeskunde, UZ Leuven
4. End of symposium and reception - 20:55 - 21:55